Africa Contraceptive Drugs and Devices Market Report and Forecast 2024-2032

Africa Contraceptive Drugs and Devices Market Outlook

Africa contraceptive drugs and devices market size is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032, driven by the increasing number of unwanted pregnancies. The market growth is also driven by the rising initiatives by the government to create awareness among people in Africa.

Contraceptive Drugs and Devices: Introduction

Contraception is a procedure that includes the usage of drugs and devices depending on the preference and the severity of the patient. Contraception can be performed in an emergency and by choice, in both conditions there are plenty of options available in the market. These include condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUD), oral, contraceptive pills, injectables, and topical, among others. The oral pills can be used for birth control, but the administration regimen needs to be performed strictly. However, devices such as intrauterine devices are inserted in the uterus and a woman can prevent pregnancies for up to 10 years.

Africa Contraceptive Drugs and Devices Market Analysis

The market growth is driven by the increased initiative by the government to create awareness among people in Africa. With an increase in advancements including drugs and devices for contraception, the Africa contraceptive drugs and devices market growth is expected to follow an upward trajectory. Pharmaceutical companies in Africa are trying to innovate contraceptive products for their better utilization and enhanced efficacy. For example, a South African company has been working on a new version of vaginal rings to protect women against HIV. This dapivirine vaginal ring is a long-acting form of HIV prevention and has been approved for use in eleven sub-Saharan African nations, according to an international nonprofit organization. Some AIDS experts have said that these vaginal rings are expected to become cheaper in the longer run and will be easily available in the market. Such innovative developments may also provide ideas and knowledge to the developers to create something similar to help women against unwanted pregnancies, which will further contribute to the Africa contraceptive drugs and devices market share. 

Additionally, the availability of condoms and other contraceptive drugs and devices has somehow curbed the restraining factors of the market. However, there is a crucial gap in the market which has provided the opportunity for pharmaceutical companies and NGOs to develop and create awareness against contraception among people, especially women. For example, the initiatives by the World Health Organization aspiring to achieve universal access and the realization of sexual and reproductive health services is an essential responsibility to fulfill the pledge of the 2030 Agenda for Sustainable Development that ‘no one will be left behind’ are expected to propel the market growth.

Africa Contraceptive Drugs and Devices Market Segmentations

Market Breakup by Product

• Drugs
  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives

• Devices
  • Condoms  
  • Diaphragms
  • Cervical Caps 
  • Sponges
  • Vaginal Ring
  • Intra Uterine Devices (IUD) 
  • Others

• Others

Market Breakup by Gender

• Male

• Female

Market Breakup by Distribution Channel

• Hospital Pharmacy

• Retail Pharmacy

• Clinics

• Online Channel 

• Public Channel and NGOs

• Others

Africa Contraceptive Drugs and Devices Market Overview

The growth of the market is driven by the increasing awareness about unwanted pregnancies and family planning in African regions. Africa is a low-economy, low-income region, lacking appropriate knowledge of family planning, resulting in unwanted pregnancies. Non-profit organizations, such as the World Health Organization (WHO), play a crucial role in developing knowledge in regions like Africa regarding contraceptive drugs and devices. Due to the increased initiatives by such organizations, awareness among people has substantially increased, and the market is witnessing increased demand, propelling the contraceptive drugs and devices market growth.

Furthermore, the market growth is driven by the rising prevalence of sexually transmitted diseases among the population. According to the data released by the National Institute of Health (NIH), South Africa has the largest count of people suffering from HIV (PLWH) of any country in the world. It is estimated by the Joint United Nations Programme on HIV/AIDS (UNAIDS), that prevalence in South Africa is 8 million with an incidence of 7 per 1000 among 15–49-year-olds. This data is more than enough to predict the growth in contraceptive drugs and devices market demand in the forecast period.

Africa Contraceptive Drugs and Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the Africa contraceptive drugs and devices market are as follows:

• Merck & Co. Inc.

• Mylan N.V.

• Pfizer Inc.

• Bayer AG

• AbbVie

• Lupin Limited

• Teva Pharmaceutical Industries Ltd

• Medicines360

• Durex

• Mankind Pharma

• Johnson & Johnson

• Gabler Medical

• Sinapi Biomedical

• Church & Dwight

• CooperSurgical

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report